3 - 7 December 2020
17th Global Cardio
Clinical Trialists Forum
How can I (or my colleague) apply?
Please contact the chairs of CVCT
Pr Faiez Zannad
Dr Bertram Pitt
What Can the Fellowship Offer?
Work with Executive/Steering Committees and clinician scientists in Boehringer Ingelheim on CV outcome trial(s).
Undertake analyses of datasets that complements the fellow’s interest.
APPLICATION DEADLINE: January 31, 2021
Boehringer Ingelheim Fellowship Program
DVANCED FELLOWSHIP IN CV TRIALS
What problem are we trying to solve?
Without a steady supply of talent, innovation in outcome-based cardiovascular drug/device development is at risk.
Currently, there are only limited opportunities, if any, for clinical academics to gain expertise in the conduct of these global trials.
Why Boehringer Ingelheim?
Boehringer Ingelheim has a strong legacy of cardiovascular outcome trials, including EMPA-REG OUTCOME and Emperor-Reduced trials.
As a family-owned company, Boehringer Ingelheim plans in generations.
This partnership with CVCT is a unique opportunity to nurture future leaders in cardiovascular medicine.